Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Cancer pain | D000072716 | — | G89.3 | — | — | 1 | — | — | 1 |
Adenocarcinoma | D000230 | — | — | — | — | 1 | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | — | 1 | — | — | 1 |
Endocrine gland neoplasms | D004701 | EFO_0003769 | D35 | — | — | 1 | — | — | 1 |
Oncogenes | D009857 | — | — | — | — | 1 | — | — | 1 |
Drug common name | Ganitumab |
INN | ganitumab |
Description | Ganitumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743024 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | CK1441RCZ8 (ChemIDplus, GSRS) |